Effect of Nano-Hyaluronic Acid in Intrabony Defects Treated With Minimally Invasive Non-Surgical Technique
2026年5月15日 更新者:Mustafa Hussein Alshebli、Cairo University
Clinical Evaluation of Nano-Hyaluronic Acid as an Adjunctive to Minimally Invasive Non-Surgical Technique in the Treatment of Deep Intrabony Defects: Randomized Controlled Clinical Trial
This randomized controlled clinical trial aims to evaluate the effectiveness of using nano-hyaluronic acid (nano-HyA) gel alongside a minimally invasive non-surgical technique (MINST) to treat deep intrabony defects in patients with Stage II and III periodontitis.
While MINST is a proven method for cleaning deep periodontal pockets without the need for traditional surgery , the addition of nano-HyA may further enhance soft tissue healing, reduce inflammation, and promote regeneration.
Participants in the study will be randomly assigned to one of two groups.
The test group will receive the MINST procedure combined with the application of nano-HyA gel into the periodontal pocket, while the control group will receive the MINST procedure alone.
The primary goal of the study is to measure the decrease in probing pocket depth over a 6-month follow-up period to determine if the adjunctive use of nano-HyA provides superior clinical and radiographic outcomes compared to non-surgical treatment alone
研究概览
地位
主动,不招人
研究类型
介入性
注册 (实际的)
28
阶段
- 阶段2
- 阶段1
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Cairo Governorate
-
Cairo、Cairo Governorate、埃及
- Faculty of Dentistry, Cairo University
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
不
描述
Inclusion Criteria:
- Males and females aged ≥ 18 years.
- Patients with a diagnosis of periodontitis (stage II or III).
- At least one tooth with ≥5 mm PPD and CAL and evidence of radiographic bone loss.
- Presenting with at least 1 intrabony defect, with a radiographic intra-bony component ≥3 mm.
Exclusion Criteria:
- Patients with systemic diseases.
- Pregnant or lactating females.
- Tobacco smokers (≥ 10 cigarettes per day).
- Multi-rooted teeth with class II and class III furcation defects.
- Third molars.
- Teeth with grade III mobility.
- Peri-apical pathology and acute abscess.
- Non-surgical or surgical periodontal treatment in the past 12 months.
- Prolonged treatment with antibiotics or anti-inflammatory agents within 6 months before periodontal therapy.
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:MINST alone
Participants receive the minimally invasive non-surgical technique (MINST) alone without adjunctive treatment
|
Subgingival debridement using thin ultrasonic tips and additional instrumentation with Gracey mini-curettes, deliberately avoiding subgingival rinsing to support blood clot stabilization
|
|
实验性的:MINST + nano-hyaluronic acid
Participants receive MINST combined with adjunctive nano-hyaluronic acid
|
Subgingival debridement using thin ultrasonic tips and additional instrumentation with Gracey mini-curettes, deliberately avoiding subgingival rinsing to support blood clot stabilization
Pockets associated with intrabony defects are filled with nano-HyA paste immediately after subgingival debridement
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Pocket Depth (PD)
大体时间:"From enrollment to the end of treatment at 24 weeks"
|
Measured in millimeters (mm) from the gingival margin to the bottom of the gingival sulcus using a UNC-15 periodontal probe.
Each tooth is probed at 6 sites with a light force not exceeding 25 grams.
|
"From enrollment to the end of treatment at 24 weeks"
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Full-Mouth Plaque Score (FMPS)
大体时间:From enrollment to the end of treatment at 24 weeks
|
Assessed as the percentage of sites with plaque.
|
From enrollment to the end of treatment at 24 weeks
|
|
Full-Mouth Bleeding Score (FMBS)
大体时间:From enrollment to the end of treatment at 24 weeks
|
Assessed as the percentage of sites with bleeding upon probing.
|
From enrollment to the end of treatment at 24 weeks
|
|
Clinical Attachment Level (CAL)
大体时间:From enrollment to the end of treatment at 24 weeks
|
Measured in millimeters (mm) from the cemento-enamel junction to the bottom of the pocket.
|
From enrollment to the end of treatment at 24 weeks
|
|
Gingival Recession (GR)
大体时间:From enrollment to the end of treatment at 24 weeks
|
Measured in millimeters (mm) from the cemento-enamel junction to the gingival margin.
|
From enrollment to the end of treatment at 24 weeks
|
|
Radiographic Defect Angle (RDA)
大体时间:From enrollment to the end of treatment at 24 weeks
|
Measured in degrees (°).
|
From enrollment to the end of treatment at 24 weeks
|
|
Patient Satisfaction
大体时间:From enrollment to the end of treatment at 24 weeks
|
Assessed via a Likert-scale questionnaire.
The scale ranges from 1 to 5, where 1 indicates "Very Dissatisfied" and 5 indicates "Very Satisfied".
Higher scores represent a better outcome.
|
From enrollment to the end of treatment at 24 weeks
|
|
Cost Effectiveness
大体时间:From enrollment to the end of treatment at 24 weeks
|
Evaluated through a health economic analysis, measured as currency per unit effect.
|
From enrollment to the end of treatment at 24 weeks
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2025年7月15日
初级完成 (估计的)
2026年8月1日
研究完成 (估计的)
2026年8月29日
研究注册日期
首次提交
2026年5月11日
首先提交符合 QC 标准的
2026年5月15日
首次发布 (实际的)
2026年5月19日
研究记录更新
最后更新发布 (实际的)
2026年5月19日
上次提交的符合 QC 标准的更新
2026年5月15日
最后验证
2026年5月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.